Natriuretic peptide system gene variants are associated with ventricular dysfunction after coronary artery bypassgrafting

Anesthesiology

Volumn 110, Issue 4, 2009, Pages 738-747

  Fox, Amanda A ^a   Collard, Charles D ^b   Shernan, Stanton K ^a   Seidman, Christine E ^e   Seidman, Jonathan G ^c   Liu, Kuang Yu ^a   Muehlschlegel, Jochen D ^a   Perry, Tjorvi E ^a   Aranki, Sary F ^a   Lange, Christoph ^d   Herman, Daniel S ^c   Meitinger, Thomas ^e   Lichtner, Peter ^e   Body, Simon C ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR RECEPTOR; CRN PROTEIN, HUMAN; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR B; NATRIURETIC PEPTIDE RECEPTOR C; NPPA PROTEIN, HUMAN; SERINE PROTEINASE; TROPONIN I;

ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CORIN GENE; CORONARY ARTERY BYPASS GRAFT; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEART FAILURE; HEART VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NPPA GENE; NPPB GENE; NPPC GENE; NPR1 GENE; NPR2 GENE; NPR3 GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; BLOOD; CLINICAL TRIAL; ETHNOLOGY; EUROPE; GENETICS; INFORMATION PROCESSING; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; CORONARY ARTERY BYPASS; DATA COLLECTION; EUROPE; FEMALE; GENES; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RISK FACTORS; SERINE ENDOPEPTIDASES; TROPONIN I; VENTRICULAR DYSFUNCTION; YOUNG ADULT;

EID: 65349196101     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31819c7496     Document Type: Article

References (39)

1. Hutłess R, Kazanegra R, Madani M, Bhalla MA, Tulua-Tata A, Chen A, Clopton P, James C, Chiu A, Maisel AS: Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 2004; 43:1873-9
2. Fox AA, Shernan SK, Collard CD, Liu KY, Aranki SF, DeSantis SM, Jarolim P, Body SC: Preoperative B-type natriuretic peptide is as independent predictor of ventricular dysfunction and mortality after primary coronary artery bypass grafting. J Thorac Cardiovasc Surg 2008; 136:452-61
3. Provenchere S, Berroeta C, Reynaud C, Baron G, Poirier I, Desmonts JM, Iung B, Dehoux M, Philip I, Benessiano J: Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: Association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med 2006; 34:995-1000
4. Cea LB: Natriuretic peptide family: New aspects. Curr Med Chem Cardiovasc Hematol Agents 2005; 3:87-98
5. Itoh H, Suga S, Ogawa Y, Komatsu Y, Tamura N, Igaki T, Yamashita J, Ikeda T, Doi K, Chun TH, Inoue M, Matsuda K, Yoshimasa T, Ueda M, Ban T, Nakao K: Signiícance of vascular natriuretic peptide system in vascular remodeling in humans and its application to gene therapy. Ann N Y Acad Sci 1997; 811:533-41
6. Kawakami R, Saito Y, Kishimoto I, Harada M, Kuwahara K, Takahashi N, Nakagawa Y, Nakanishi M, Tanimoto K, Usami S, Yasuno S, Kinoshita H, Chusho H, Tamura N, Ogawa Y, Nakao K: Overexpression of brain natriuretic peptide facilitates neutrophil iníltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction. Circulation 2004; 110:3306-12
7. Cerisano G, Pucci PD, Sulla A, Tommasi M, Raspanti S, Santoro GM, Antoniucci D: Relation between plasma brain natriuretic peptide, serum indexes of collagen type I turnover, and left ventricular remodeling after reperfused acute myocardial infarction. Am J Cardiol 2007; 99:651-6
8. Soeki T, Kishimoto I, Okumura H, Tokudome T, Horio T, Mori K, Kangawa K: C-type natriuretic peptide, a novel antiíbrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction. J Am Coll Cardiol 2005; 45:608-16
9. Tamura N, Ogawa Y, Chusho H, Nakamura K, Nakao K, Suda M, Kasahara M, Hashimoto R, Katsuura G, Mukoyama M, Itoh H, Saito Y, Tanaka I, Otani H, Katsuki M: Cardiac íbrosis in mice lacking brain natriuretic peptide. Proc Natl Acad SciUSA 2000; 97:4239-44
10. DSouza SP, Yellon DM, Martin C, Schulz R, Heusch G, Onody A, Ferdinandy P, Baxter GF: B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening. Am J Physiol Heart Circ Physiol 2003; 284: H1592-600
11. Ren B, Shen Y, Shao H, Qian J, Wu H, Jing H: Brain natriuretic peptide limits myocardial infarct size dependent of nitric oxide synthase in rats. Clin Chim Acta 2007; 377:83-7
12. Hobbs A, Foster P, Prescott C, Scotland R, Ahluwalia A: Natriuretic peptide receptor-C regulates coronary blood łow and prevents myocardial ischemia/ reperfusion injury: Novel cardioprotective role for endothelium-derived C-type natriuretic peptide. Circulation 2004; 110:1231-5
13. Burley DS, Hamid SA, Baxter GF: Cardioprotective actions of peptide hormones in myocardial ischemia. Heart Fail Rev 2007; 12:279-91
14. DSouza SP, Davis M, Baxter GF: Autocrine and paracrine actions of natriuretic peptides in the heart. Pharmacol Ther 2004; 101:113-29
15. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347:161-7
16. Feringa HH, Schouten O, Dunkelgrun M, Bax JJ, Boersma E, Elhendy A, de Jonge R, Karagiannis SE, Vidakovic R, Poldermans D: Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery. Heart 2007; 93:226-31
17. Mahla E, Baumann A, Rehak P, Watzinger N, Vicenzi MN, Maier R, Tiesenhausen K, Metzler H, Toller W: N-terminal pro-brain natriuretic peptide identiíes patients at high risk for adverse cardiac outcome after vascular surgery. ANESTHESIOLOGY 2007; 106:1088-95
18. Morrow DA, de Lemos JA, Sabatine MS, Murphy SA, Demopoulos LA, DiBattiste PM, McCabe CH, Gibson CM, Cannon CP, Braunwald E: Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol 2003; 41:1264-72
19. Conen D, Glynn RJ, Buring JE, Ridker PM, Zee RY: Natriuretic peptide precursor a gene polymorphisms and risk of blood pressure progression and incident hypertension. Hypertension 2007; 50:1114-9
20. Sarzani R, Dessi-Fulgheri P, Salvi F, Serenelli M, Spagnolo D, Cola G, Pupita M, Giantomassi L, Rappelli A: A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hypertensives. J Hypertens 1999; 17:1301-5
21. Pitzalis MV, Sarzani R, Dessi-Fulgheri P, Iacoviello M, Forleo C, Lucarelli K, Pietrucci F, Salvi F, Sorrentino S, Romito R, Guida P, Rappelli A, Rizzon P: Allelic variants of natriuretic peptide receptor genes are associated with family history of hypertension and cardiovascular phenotype. J Hypertens 2003; 21:1491-6
22. Rubattu S, Ridker P, Stampfer MJ, Volpe M, Hennekens CH, Lindpaintner K: The gene encoding atrial natriuretic peptide and the risk of human stroke. Circulation 1999; 100:1722-6
23. Rubattu S, Stanzione R, Di Angelantonio E, Zanda B, Evangelista A, Tarasi D, Gigante B, Pirisi A, Brunetti E, Volpe M: Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans. Stroke 2004; 35:814-8
24. Gruchala M, Ciecwierz D, Wasag B, Targonski R, Dubaniewicz W, Nowak A, Sobiczewski W, Ochman K, Romanowski P, Limon J, Rynkiewicz A: Association of the ScaI atrial natriuretic peptide gene polymorphism with nonfatal myocardial infarction and extent of coronary artery disease. Am Heart J 2003; 145:125-31
25. Freedman ML, Reich D, Penney KL, McDonald GJ, Mignault AA, Palterson N, Gabriel SB, Topol EJ, Smoller JW, Pato CN, Pato MT, Petryshen TL, Kolonel LN, Lander ES, Sklar P, Henderson B, Hirschhorn JN, Altshuler D: Assessing the impact of population stratiícation on genetic association studies. Nat Genet 2004; 36:388-93
26. Bersaglieri T, Sabeti PC, Patterson N, Vanderploeg T, Schaffner SF, Drake JA, Rhodes M, Reich DE, Hirschhorn JN: Genetic signatures of strong recent positive selection at the lactase gene. Am J Hum Genet 2004; 74:1111-20
27. Fisher JD: New York Heart Association classiícation. Arch Intern Med 1972; 129:836
28. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC: PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81:559-75
29. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21:263-5
30. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D: The structure of haplotype blocks in the human genome. Science 2002; 296:2225-9
31. Vassalle C, Andreassi MG, Prontera C, Fontana M, Zyw L, Passino C, Emdin M: Inłuence of ScaI and natriuretic peptide (NP) clearance receptor polymorphisms of the NP System on NP concentration in chronic heart failure. Clin Chem 2007; 53:1886-90
32. Takeishi Y, Toriyama S, Takabatake N, Shibata Y, Konta T, Emi M, Kato T, Kawata S, Kubota I: Linkage disequilibrium analyses of natriuretic peptide precursor B locus reveal risk haplotype conferring high plasma BNP levels. Biochem Biophys Res Commun 2007; 362:480-4
33. Lajer M, Tarnow L, Jorsal A, Parving HH: Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients. Nephrol Dial Transplant 2007; 22:3235-9
34. Rubattu S, Bigatti G, Evangelista A, Lanzani C, Stanzione R, Zagato L, Manunta P, Marchitti S, Venturelli V, Bianchi G, Volpe M, Stella P: Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J Am Coll Cardiol 2006; 48:499-505
35. Dedoussis GV, Maumus S, Skoumas J, Choumerianou DM, Pitsavos C, Stefanadis C, Visvikis-Siest S: Natriuretic peptide Val7Met substitution and risk of coronary artery disease in Greek patients with familial hypercholesterolemia. J Clin Lab Anal 2006; 20:98-104
36. Martinez-Rumayor A, Richards AM, Burnett JC, Januzzi JL Jr: Biology of the natriuretic peptides. Am J Cardiol 2008; 101:3-8
37. Matsukawa N, Grzesik WJ, Takahashi N, Pandey KN, Pang S, Yamauchi M, Smithies O: The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci USA 1999; 96:7403-8
38. William M, Hamilton EJ, Garcia A, Bundgaard H, Chia KK, Figtree GA, Rasmussen HH: Natriuretic peptides stimulate the cardiac sodium pump via NPR-C-coupled NOS activation. Am J Physiol Cell Physiol 2008; 294:C1067-73
39. Medina MW, Gao F, Ruan W, Rotter JI, Krauss RM: Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatin. Circulation 2008; 118: 355-62